WellMedr Review 2026
Reviewed August 7, 2026 · Both — compounded semaglutide and tirzepatide (not FDA-approved) plus brand-name Ozempic and Zepbound
Visit WellMedr WebsiteOverview
WellMedr is a Florida-registered direct-to-consumer telehealth platform selling compounded semaglutide and tirzepatide, brand-name Ozempic and Zepbound, a 'microdose' GLP-1 line, injectable NAD+, and adjacent categories including sexual health, hair loss and testosterone. Its advertised entry prices — compounded semaglutide 'Starting At $59 a month' and tirzepatide 'Starting At $99 a month' — are the lowest we have recorded anywhere in this directory. The company says its clinical services run through 'OpenLoop Health and other networks of U.S.-licensed clinicians', which is a real, verifiable white-label clinician network operating in all 50 states, and it discloses on its own pages that compounded medications are not FDA-approved. Those are genuine positives. The problem is that WellMedr's marketing pages and its own legal policy pages describe materially different products. The sign-up page advertises a '90 day money back guarantee' and 'cancel or change anytime'; the refund and cancellation policy contains no weight-loss guarantee at all and states that orders become 'final and non-refundable' once medical intake is approved. The marketing pages price in months and say medication ships 'every 4 weeks'; the refund policy states the subscription renews every 21 days. We could not reconcile these from the published documents, and the Better Business Bureau has independently posted a pattern-of-complaint alert against the company covering billing, advertising and sales practices. This review is written around those conflicts because they determine what a reader will actually pay and whether they can get out.
Medications Offered
Brand-name or compounded: Both — compounded semaglutide and tirzepatide (not FDA-approved) plus brand-name Ozempic and Zepbound
- Compounded semaglutide (injectable) — advertised 'Starting At $59 a month'
- Compounded tirzepatide (injectable) — advertised 'Starting At $99 a month'
- Brand-name Ozempic — advertised 'starting at $1,399'
- Brand-name Zepbound — advertised 'starting at $1,599'
- Microdose line (semaglutide, tirzepatide, oral tirzepatide + inositol, combinations with B12, NAD+, L-carnitine) — $199/month for the formulations that carry a displayed price
- Injectable NAD+ — 'Starting at $99/month', 500mg and 1000mg
- Homepage promotion at time of checking: '50% off your first month' on compounded semaglutide and tirzepatide
Consultation Process
Online intake
WellMedr advertises the intake as taking about 3 minutes on the landing page and around 15 minutes in the process description, with 'No commitment • Clinician review required'. No payment card requirement is stated at this stage.
Clinician review
A licensed clinician reviews the intake, which the FAQ says happens within 1-2 business days. WellMedr states its assessment 'does not create a doctor-patient relationship' and that providers retain discretion to decline to prescribe.
Plan and prescription
If approved, a plan and prescription are issued and routed to a pharmacy. This is the point that matters commercially: the refund policy states that once intake 'has been approved and transmitted to a licensed medical provider and/or pharmacy for review or fulfillment, your order becomes final and non-refundable'.
Delivery and recurring billing
Standard delivery is stated as 3-5 business days after approval, with free and discreet shipping. Billing then recurs automatically — every 21 days according to the refund and cancellation policy, though the sales pages describe shipments 'every 4 weeks'.
Eligibility
- Adults; no BMI threshold, age range or disqualifying-condition list is published
- Eligibility is determined during the intake — WellMedr says 'eligibility is checked during sign-up'
- No lab work requirement is published; the FAQ does not address labs at all
- Standard GLP-1 contraindications apply and should be raised with the clinician (see warnings)
- US only; no state list or exclusion list is published
Provider Involvement
WellMedr states that clinical services are provided through 'OpenLoop Health and other networks of U.S.-licensed clinicians'. OpenLoop is a genuine white-label telehealth infrastructure company that handles clinician sourcing, multi-state licensing and credentialing across all 50 states, so the underlying clinician network is real and credentialed — a meaningful point in WellMedr's favour, and more than most competitors disclose. What is missing is anything above that layer: no medical director, no named prescribing clinician and no clinical leadership is published anywhere on the site. Unlimited messaging with clinicians is included in all plans according to the sales pages.
Lab Requirements
None published. The FAQ does not mention laboratory testing, and no required panel appears on the weight-loss or get-started pages. Providers that publish lab requirements (creatinine, eGFR, A1c or fasting glucose) give you a stronger signal of clinical rigour; WellMedr does not. Ask what monitoring is expected before you start.
Pharmacy Fulfillment
Not named. WellMedr says medication is dispensed by 'U.S. licensed pharmacies' and produced in 'FDA-registered facilities', and that it 'partners with certified U.S. pharmacies'. It does not identify any facility or state whether its compounding partners are 503A pharmacies or 503B outsourcing facilities. That distinction is not cosmetic in 2026 — see the regulatory warning below. Ask for the pharmacy name and its 503A/503B status in writing before ordering.
Shipping Frequency
The sales pages state medication is 'shipped every 4 weeks' with 'On-Time Refills, Always'. The refund and cancellation policy states the subscription 'will automatically renew every 21 days'. Those are different intervals — a three-week billing cycle against a four-week shipping cycle — and WellMedr does not reconcile them on any page we could find. Get the actual billing interval confirmed in writing before you enter a card.
Membership Fees vs. Medication Fees
Membership fees
No separate membership or platform fee is advertised, and the company markets this as a differentiator. Medication pricing is presented as all-inclusive of consultation, clinician messaging and shipping. Note that the absence of a membership fee does not make the headline price a monthly price — see the billing interval issue.
Medication fees
- Compounded semaglutide: advertised from $59 per cycle
- Compounded tirzepatide: advertised from $99 per cycle
- Microdose formulations with a displayed price: $199 per cycle
- Injectable NAD+: from $99 per cycle
- Brand-name Ozempic: from $1,399; Zepbound: from $1,599
- Shipping: free, included
- Advertised intro offer: 50% off the first month on compounded plans
Cancellation & Refund Policy
Cancellation
Published, but internally inconsistent and materially narrower than the marketing suggests. The sales pages say 'Cancel or change anytime' and 'no penalties'. The refund and cancellation policy says cancellation requests 'must be submitted at least 48 hours prior to your scheduled renewal date' in one passage and 'at least 72 hours prior to your billing date' in another. With a 21-day cycle and a 48-72 hour notice window, the practical effect is that you must diarise a moving billing date and act three days ahead of it every cycle. Miss it and you are billed for another cycle, at which point the no-refunds-after-intake-approval clause applies.
Refunds
This is the most important section of this review. WellMedr's sign-up page advertises, in capitals, 'MONEY BACK GUARANTEE: IF YOU DON'T LOSE WEIGHT IN 90 DAYS WE WILL REFUND 100% OF YOUR MONEY'. We looked for that guarantee in the company's refund and cancellation policy and it is not there — no weight-loss guarantee of any kind appears in the policy. What the policy does say is: 'Once a purchase is completed and your medical intake has been approved and transmitted to a licensed medical provider and/or pharmacy for review or fulfillment, your order becomes final and non-refundable... Orders cannot be canceled, or refunded once this process has started, regardless of whether medication has shipped.' It also notes that federal law generally prohibits returning prescription medication for refund. For multi-month bundles, 'Refunds will be calculated as a prorated amount, based on the number of months of medication shipments you have already received and the regular (non-bundle) pricing' — meaning early exit is repriced at the higher non-bundle rate. If the 90-day guarantee matters to your decision, get its exact terms in writing from WellMedr before paying, because the published policy does not support it.
Insurance
WellMedr does not advertise insurance billing. The FAQ says only that 'Our pricing is often more affordable than traditional insurance co-pays', which is a marketing comparison rather than a coverage statement. Treat this as a cash-pay service. If you have insurance that covers GLP-1s for weight management, a provider that bills your benefit will almost always beat any cash-pay compounded price.
HSA / FSA
Not addressed in the FAQ or the policy pages we reviewed. Third-party affiliate articles assert FSA/HSA eligibility, but we could not verify that on WellMedr's own site and are not treating those articles as a source. Ask directly.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Unlimited messaging with licensed clinicians, included in plans
- Care platform with progress tracking and what the company calls 'AI-enhanced guidance'
- Medical weight-care coach referenced on the weight-loss page
- Free and discreet shipping on all prescriptions
- Self-service dashboard that WellMedr says lets you 'manage, pause, or cancel your plan anytime'
State Availability
No state list is published. WellMedr says 'We currently ship to all U.S. states where our services are available' and that 'We are expanding rapidly — eligibility is checked during sign-up'. That is a circular statement — it tells you nothing before you begin an intake. Several compounded GLP-1 providers exclude specific states for regulatory reasons, so the absence of a list is a genuine gap.
Pros
- Lowest advertised compounded entry prices we have seen — semaglutide from $59 and tirzepatide from $99
- Clinical services delivered through OpenLoop Health, a large named and credentialed US clinician network
- States plainly on its own pages that compounded medications are not FDA-approved
- Brand-name Ozempic and Zepbound offered alongside compounded product
- Free shipping included; no separate membership fee advertised
- Publishes a refund and cancellation policy rather than hiding terms behind checkout
Cons
- Subscriptions renew every 21 days, not monthly — the real annual cost is roughly 45% above what 'a month' implies
- The '90 day money back guarantee' advertised on the sign-up page does not appear anywhere in the refund policy
- The refund policy states orders are final and non-refundable once intake is approved, 'regardless of whether medication has shipped'
- The cancellation notice window is published as both 48 hours and 72 hours in the same policy
- BBB rates the company F, is not accrediting it, and has posted a pattern-of-complaint alert for billing, advertising and sales practices
- Microdosing pages publish average weight-loss and side-effect figures with no source, then disclaim that the products 'have not been studied for specific health outcomes'
- No pharmacy is named; no medical director or named clinician is published
- No state list, no BMI threshold and no lab requirements published
Who WellMedr May Be Best For
- Price-driven shoppers who will read the refund and cancellation policy in full before paying
- Patients who want compounded and brand-name options on one platform and will ask for the pharmacy name in writing
- People comfortable managing a short cancellation window on a 21-day billing cycle
Limitations
- Advertised guarantee is unsupported by the published refund policy
- 21-day billing cycle marketed with monthly pricing language
- BBB F rating with an active pattern-of-complaint alert
- Unsourced efficacy and side-effect statistics on the microdosing pages
- No named pharmacy, no named clinical leadership, no state list, no BMI or lab criteria
Reputation & Trust
The independent signal here is poor and it is the reason for this rating. The Better Business Bureau rates WellMedr LLC (7901 4th St N Ste 300, St Petersburg, FL 33702; business start date 29 May 2025, BBB file opened 31 March 2026) an F, does not accredit it, and has recorded 41 complaints. BBB has posted a pattern alert stating: 'It came to BBB's attention that this company has received consumer complaints alleging a pattern of billing, advertising, and sales practice issues.' The complaint categories reported include billing, advertising, sales practices, subscription cancellation difficulty and refund requests — which map precisely onto the documentary conflicts we found on the site itself. That correspondence is what moves this from a paperwork quibble to a rating. Trustpilot is more favourable, showing roughly 4 out of 5 across approximately 887 reviews; we were unable to load Trustpilot directly to verify the distribution and are reporting that figure as indicative only. Note also that search results for this brand are dominated by affiliate-run 'review' sites quoting prices ($88 semaglutide, $158 tirzepatide) that do not match the company's own published figures — treat that layer of coverage, including this page's own commercial interest, with appropriate scepticism.
What Makes WellMedr Different
- Lowest advertised compounded GLP-1 entry price in this directory, at $59
- Names OpenLoop Health as its clinician network, which most competitors do not do
- Wide catalogue: standard GLP-1s, microdosing, NAD+, sexual health, hair loss, testosterone
- Brand-name and compounded routes offered on the same platform
- No membership fee stacked on top of medication
Our Verdict
WellMedr scores 2/5. The proposition is genuinely attractive on paper — the lowest advertised compounded prices in this directory, no membership fee, free shipping, brand-name options alongside compounded, a named and credentialed clinician network in OpenLoop Health, and an honest statement on its own pages that compounded medication is not FDA-approved. Several better-rated providers disclose less. What we cannot get past is that WellMedr's marketing pages and its own legal policy describe two different contracts. The sign-up page promises a 100% refund if you do not lose weight in 90 days and 'cancel anytime'; the refund policy contains no such guarantee and makes orders final and non-refundable the moment intake is approved. Pricing is quoted per month while the policy renews billing every 21 days, which on the company's own terms puts the real annual cost around 45% above the advertised reading. The cancellation window is published as both 48 and 72 hours. And the microdosing pages publish average weight-loss figures for products the same pages say have not been studied for outcomes. Any one of these might be sloppy copywriting. Together, and alongside a BBB F rating with an active pattern alert for billing, advertising and sales practices, they form a consistent picture that we do not think a reader should walk into unwarned. If the price still appeals, do three things before paying: get the billing interval in writing, get the 90-day guarantee terms in writing, and ask which pharmacy compounds your medication and whether it is 503A or 503B. If you want a cheap compounded programme with terms that hold up on paper, Ozari Health, CoraDoc and Cora Health are better starting points.
Alternatives to WellMedr
Genuinely low compounded pricing from $86/month across all 50 states with no prepayment required to reach the headline rate.
The clearest exit terms in this market — a full refund if you are declined or cancel before your order ships.
Comparable all-in pricing from a provider that actually names its 503A pharmacy partners.
If you want FDA-approved medication and published eligibility criteria rather than compounded product.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
How much does WellMedr actually cost per year?
More than the advertised figure implies. WellMedr advertises compounded semaglutide 'Starting At $59 a month' and tirzepatide 'Starting At $99 a month', but its refund and cancellation policy states the subscription 'will automatically renew every 21 days'. A 21-day cycle is about 17.4 billing events a year rather than 12, so on the company's own published terms $59 per cycle works out near $1,025 a year and $99 per cycle near $1,721 a year — roughly 45% above what a calendar-month reading suggests. These are our calculations from WellMedr's published terms, not figures the company quotes, and the sales pages separately describe shipments 'every 4 weeks'. Confirm your exact billing interval in writing before entering a card.
Is the 90-day money-back guarantee real?
We could not verify it. WellMedr's sign-up page advertises 'MONEY BACK GUARANTEE: IF YOU DON'T LOSE WEIGHT IN 90 DAYS WE WILL REFUND 100% OF YOUR MONEY'. No such guarantee appears in the company's own refund and cancellation policy, which instead states that once your intake is approved and sent to a provider or pharmacy, 'your order becomes final and non-refundable... regardless of whether medication has shipped'. If this guarantee is part of why you are signing up, ask WellMedr to send you its terms and conditions in writing first.
Is WellMedr legitimate?
It is a real, operating company — WellMedr LLC, registered in St Petersburg, Florida, with clinical services delivered through OpenLoop Health, an established US clinician network. Legitimacy is not the same as good consumer terms, though. The Better Business Bureau rates it F, does not accredit it, has logged 41 complaints and has posted an alert stating the company 'has received consumer complaints alleging a pattern of billing, advertising, and sales practice issues'. WellMedr also displays a LegitScript certification badge on its site; we were not able to confirm that listing in LegitScript's public lookup, so treat the badge as a company claim until you verify it yourself.
Is WellMedr's compounded tirzepatide the same as Zepbound?
No. Compounded semaglutide and tirzepatide are not FDA-approved. They have not been evaluated by the FDA for safety, efficacy or quality, and they are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound beyond sharing an active ingredient. WellMedr does state this on its own pages, which is to its credit. Potency, purity and sterility depend entirely on the compounding facility — which WellMedr does not name.
Can I trust the weight-loss numbers on the microdosing page?
We would not rely on them. WellMedr's microdosing pages state 'Zero side effect for 70%+ of members', 'Average weight loss is 10-17 pounds within 60 days' and 'Average weight loss in clinical programs: 25-40 lbs', with no study, population or source attached. The same pages carry the disclaimer that 'Microdosed GLP-1/GIP compounds have not been studied for specific health outcomes'. A company cannot both publish average outcomes for a product and disclaim that the product has not been studied for outcomes. Microdosing is not an FDA-approved dosing strategy and has no outcome evidence base comparable to standard dosing.
Which states does WellMedr serve?
It does not say. WellMedr states only that it ships 'to all U.S. states where our services are available' and that eligibility is checked at sign-up. If you need to know before starting an intake, contact the company directly.
How do I cancel?
WellMedr says you can 'manage, pause, or cancel your plan anytime' from your dashboard. The refund policy is stricter: cancellation must be submitted at least 48 hours before your renewal date according to one passage, and at least 72 hours before your billing date according to another. Because billing runs on a 21-day cycle, the safest approach is to treat the deadline as 72 hours and diarise it each cycle. Cancelling does not produce a refund for an order whose intake has already been approved.
Important Notes & Warnings
- This review is informational only and is not medical advice. Consult a licensed clinician before starting, changing or stopping any GLP-1 treatment.
- Compounded semaglutide and tirzepatide are NOT FDA-approved, have not been evaluated by the FDA for safety, efficacy or quality, and are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound.
- BILLING: WellMedr's own policy states subscriptions renew every 21 days, while pricing is advertised per month. Budget for roughly 17 charges a year, not 12.
- REFUNDS: The '90 day money back guarantee' advertised on the sign-up page does not appear in WellMedr's published refund policy, which states orders are final and non-refundable once intake is approved, regardless of whether medication has shipped.
- The Better Business Bureau rates WellMedr F, does not accredit it, and has posted a pattern-of-complaint alert covering billing, advertising and sales practice issues.
- Weight-loss and side-effect statistics published on the microdosing pages carry no source and are contradicted by the company's own disclaimer that those formulations 'have not been studied for specific health outcomes'.
- REGULATORY: On 30 April 2026 the FDA proposed removing semaglutide, tirzepatide and liraglutide from the 503B bulks list, having found no clinical need for outsourcing facilities to compound them; the comment docket closed 29 June 2026 and a final determination was still pending when we checked. Semaglutide and tirzepatide shortages were resolved in February 2025 and December 2024 respectively, so the shortage-based justification for mass compounding no longer applies. 503A pharmacies may compound only where there is documented individualised medical necessity and the product is not essentially a copy of a commercially available drug. WellMedr does not name its pharmacy or state its 503A/503B status — ask.
- GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in pregnancy. Tell your clinician about pancreatitis, gallbladder disease, severe gastrointestinal disease, diabetic retinopathy or a history of eating disorders.
- Common side effects include nausea, vomiting, diarrhoea, constipation and abdominal pain; serious risks include pancreatitis, gallbladder disease and kidney injury from dehydration.
- Oral compounded tirzepatide, offered in the microdosing line, has no established evidence base for weight management.
Sources
- WellMedr get-started weight loss page, wellmedr.com/pages/get-started-weight-loss (accessed 7 August 2026)
- WellMedr refund and cancellation policy, wellmedr.com/pages/refund-and-cancellation-policy (accessed 7 August 2026)
- WellMedr FAQ, about, weight-loss, microdosing and NAD+ pages, wellmedr.com (accessed 7 August 2026)
- Better Business Bureau business profile, WellMedr LLC, St Petersburg FL (accessed 7 August 2026)
- OpenLoop Health, openloophealth.com — white-label clinician network scope and credentialing
- FDA proposal of 30 April 2026 to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list; public comment docket closed 29 June 2026
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 7, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.